SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for CME GROUP INC. (CME) (CIK 0001156375) (CME) — Jul 16, 2014

CME GROUP INC. (CME) (CIK 0001156375)
Date: July 16, 2014 · CIK: 0001156375 · Accession: 0000000000-14-035838

Regulatory Compliance Financial Reporting Internal Controls

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
July 16, 2014
Author
/s/ Daniel L. Gordon
Form
UPLOAD
Company
CME GROUP INC. (CME) (CIK 0001156375)

Letter

July 16, 2014 Via E -Mail James E. Parisi Chief Financial Officer CME Group Inc. 20 South Wacker Drive Chicago, IL 60606

Re: CME Group Inc. Form 10 -K for the Fiscal Ye ar Ended December 31, 20 13 Filed March 3, 2014 File No. 001 -31553

Dear Mr. Parisi :

We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing s and the company may not ass ert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filings to be certain that the filing s include the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Daniel L. Gordon

Show Raw Text
July 16, 2014

Via E -Mail
James E. Parisi
Chief Financial  Officer
CME Group Inc.
20 South Wacker Drive
Chicago, IL   60606

                 Re: CME Group Inc.
                        Form 10 -K for the Fiscal Ye ar Ended December  31, 20 13
Filed March 3,  2014
File No. 001 -31553

Dear Mr. Parisi :

We have completed our review of your filing.  We remind you that our comments
or changes to disclosure in response to our comments do not foreclose the Commission
from taking any action with respect to the company or the filing s and the company may
not ass ert staff comments as a defense in any proceeding initiated by the Commission or
any person under the federal securities laws of the United States.  We urge all persons
who are responsible for the accuracy and adequacy  of the disclosure in the filings  to be
certain that the filing s include the information the Securities Exchange Act of 1934 and
all applicable rules require.

                                                                                    Sincerely,

        /s/ Daniel L. Gordon

Daniel L. Gordon
                                                                                    Branch Chief